{"entity":{"id":"src-ema-chmp","kind":"collection","name":"EMA news and CHMP meeting highlights","aka":[],"tldr":"The EMA's CHMP highlights show Europe's approval pipeline one month ahead of European Commission decisions.","summary":"The EMA news pages and CHMP meeting highlights hold the monthly CHMP opinions: new medicines recommended, indication extensions and negative opinions. They show Europe's approval pipeline about one month ahead of the European Commission decisions. The highlights are published on the Friday of each CHMP week by the European Medicines Agency and are public. They are best read alongside the FDA OCE approval notifications to see where US and EU decisions diverge. On OnCo the source is tagged source and data, and the institution record European Medicines Agency links to it.","asOf":"2026-09-08","links":[{"label":"EMA news and CHMP meeting highlights","url":"https://www.ema.europa.eu/en/news"}],"tags":["source","data"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["ema","fda-oce"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"url":"https://www.ema.europa.eu/en/news","holds":"Monthly CHMP opinions: new medicines recommended, indication extensions, negative opinions.","license":"Public","maintainer":"European Medicines Agency"},"route":"/collections/src-ema-chmp/","neighbours":{"institution":[{"id":"ema","kind":"institution","name":"European Medicines Agency","route":"/institutions/ema/"},{"id":"fda-oce","kind":"institution","name":"FDA Oncology Center of Excellence","route":"/institutions/fda-oce/"}]}}